coriolin: sesquiterpene antibiotic isolated from Coriolus consors; structure in third source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 197171 |
| MeSH ID | M0050114 |
| Synonym |
|---|
| spiro(3h-cyclopenta(a)pentalene-3,2'-oxiran)-2(1h)-one, 1,7a-epoxyoctahydro-4,7-dihydroxy-3a,5,5-trimethyl-, stereoisomer |
| (1aalpha,3r*,3abeta,3balpha,4alpha,6aalpha,7beta,7as*)-hexahydro-4,7-dihydroxy-3a,5,5-trimethylspiro(cyclopenta(4,5)pentaleno(1,6a-b)oxirene-3(3ah),2'-oxiran)-2-(1ah)-one |
| coriolin-a |
| coriolin |
| 33404-85-2 |
| 4,7-dihydroxy-3a,5,5-trimethylhexahydro-3ah-spiro[cyclopenta[4,5]pentaleno[1,6a-b]oxirene-3,2'-oxiran]-2(1ah)-one |
| DTXSID50955031 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.04) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 4 (40.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (60.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||